Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen

I. Medizinische Klinik und Poliklinik

Klinikum / Johannes Gutenberg-Universität Mainz

Publikationen
Ergebnisse pro Seite:  10

Kataoka, Kozo; Kinoshita, Takahiro; Moehler, Markus et al.

Current management of liver metastases from gastric cancer: what is common practice? New challenge of EORTC and JCOG

GASTRIC CANCER. Bd. 20. H. 5. 2017 S. 904-912


Sprinzl, Martin F.; Galle, Peter R.

Current progress in immunotherapy of hepatocellular carcinoma

JOURNAL OF HEPATOLOGY. Bd. 66. H. 3. 2017 S. 482-484


Schimanski, Carl Christoph; Staib, Frank; Goehler, Thomas et al.

Dermatux: phase IV trial of Cetuximab plus FOLFIRI in first-line metastatic colorectal cancer receiving a pre-defined skin care

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. Bd. 143. H. 6. 2017 S. 1023-1034


Iacucci, Marietta; Daperno, Marco; Lazarev, Mark et al.

Development and reliability of the new endoscopic virtual chromoendoscopy score: the PICaSSO (Paddington International Virtual ChromoendoScopy ScOre) in ulcerative colitis

GASTROINTESTINAL ENDOSCOPY. Bd. 86. H. 6. 2017 S. 1118-+




Lutz, Jens; Jurk, Kerstin; Schinzel, Helmut

Direct oral anticoagulants in patients with chronic kidney disease: patient selection and special considerations

INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE. Bd. 10. 2017 S. 135-143


Gehrke, Nadine; Huber, Yvonne; Hoevelmeyer, Nadine et al.

Disruption of hepatic IL-1 signaling improves insulin sensitivity and hepatic inflammation in a model of non-alcoholic fatty liver disease (NAFLD).

HEPATOLOGY. Bd. 66. 2017 S. 1051A-1051A


Castven, Darko; Becker, Diana; Wilhelm, Diana et al.

Dissection of genomic and transcriptomic profiles of patient-derived liver cancer cells enables therapeutic target identification

HEPATOLOGY. Bd. 66. 2017 S. 367A-368A


Bartalena, L.; Veronesi, G.; Krassas, G. E. et al.

Does early response to intravenous glucocorticoids predict the final outcome in patients with moderate-to-severe and active Graves' orbitopathy?

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. Bd. 40. H. 5. 2017 S. 547-553